|
WDYHV1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.546810E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.681400E-01 |
| Normal-vs-Stage2 |
7.389800E-02 |
| Normal-vs-Stage3 |
6.506800E-01 |
| Normal-vs-Stage4 |
8.539000E-01 |
| Stage1-vs-Stage2 |
3.301600E-01 |
| Stage1-vs-Stage3 |
6.198200E-01 |
| Stage1-vs-Stage4 |
6.272000E-01 |
| Stage2-vs-Stage3 |
2.086000E-01 |
| Stage2-vs-Stage4 |
2.419000E-01 |
| Stage3-vs-Stage4 |
8.869600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.145600E-01 |
| Normal-vs-AfricanAmerican |
1.720590E-01 |
| Normal-vs-Asian |
6.625000E-01 |
| Caucasian-vs-AfricanAmerican |
6.226200E-01 |
| Caucasian-vs-Asian |
9.450000E-01 |
| AfricanAmerican-vs-Asian |
7.983200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.817600E-02 |
| Normal-vs-Female |
7.087000E-01 |
| Male-vs-Female |
2.641200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.110400E-01 |
| Normal-vs-Extreme_Weight |
3.983200E-01 |
| Normal-vs-Obese |
4.061600E-01 |
| Normal-vs-Extreme_Obese |
1.886470E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.009000E-01 |
| Normal_Weight-vs-Obese |
5.428800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.526100E-02 |
| Extreme_Weight-vs-Obese |
9.721600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.574400E-02 |
| Obese-vs-Extreme_Obese |
2.945700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.615200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.430990E-01 |
| Normal-vs-Age(61-80Yrs) |
2.145000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.900400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.575200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.636400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.815200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.474200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.134600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.570800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.485700E-02 |
| Normal-VS-Type2 PRCC |
2.137400E-01 |
| Normal-VS-KIRP CIMP |
1.316770E-01 |
| Normal-VS-Unclassified PRCC |
1.364980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.638400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.199100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.634600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.385750E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.246400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.599500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.948500E-02 |
| Normal-vs-N1 |
7.431200E-01 |
| Normal-vs-N2 |
1.470570E-01 |
| N0-vs-N1 |
2.111000E-01 |
| N0-vs-N2 |
1.691710E-02 |
| N1-vs-N2 |
8.958300E-02 |
|
|
